Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sheramex is a Mexican pharmaceutical company founded in 1964 that specializes in the development, manufacturing, and commercialization of generic and branded-generic medications. Headquartered in Mexico City, the company operates a production facility that adheres to Good Manufacturing Practices (GMP) to ensure the quality of its diverse product portfolio. Sheramex focuses on several key therapeutic areas, including respiratory health, infectious diseases, gastroenterology, and pain management. Its products, such as Sheramox and Sheral, are widely distributed across the Mexican healthcare system, serving both private pharmacies and public health institutions. The company remains a significant local player in the Mexican pharmaceutical market, dedicated to providing affordable and effective therapeutic options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sheramex.